Recognition and management of the cutaneous manifestations of celiac disease: A guide for dermatologists

American Journal of Clinical Dermatology

Volumn 4, Issue 1, 2003, Pages 13-20

  Collin, Pekka ^a,b   Reunala, Timo ^a  

^a TAMPERE UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; DAPSONE; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; UNCLASSIFIED DRUG;

AGRANULOCYTOSIS; ALOPECIA AREATA; ANEMIA; BLOOD TOXICITY; CELIAC DISEASE; CHROMOSOME 6; CLINICAL FEATURE; CYANOCOBALAMIN DEFICIENCY; DERMATITIS HERPETIFORMIS; DERMATOLOGY; DISEASE ASSOCIATION; DRUG EFFECT; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG TOLERABILITY; FOLLOW UP; GENE LOCUS; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; GLUTEN FREE DIET; HEADACHE; HEMOLYSIS; HISTOPATHOLOGY; HUMAN; ISCHEMIC HEART DISEASE; LIVER TOXICITY; METHEMOGLOBINEMIA; MOUTH MUCOSA; NEUROPATHY; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; PSORIASIS; REVIEW; SEROLOGY; SKIN MANIFESTATION; VITAMIN SUPPLEMENTATION; VITILIGO;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CELIAC DISEASE; DAPSONE; DERMATITIS HERPETIFORMIS; GLUTEN; HUMANS;

EID: 0037235633     PISSN: 11750561     EISSN: None     Source Type: Journal    
DOI: 10.2165/00128071-200304010-00002     Document Type: Review

References (77)

1. Fasano A, Catassi C. Current approaches to diagnosis and treatment of celiac disease: an evolving spectrum. Gastroenterology 2001; 120: 636-51
2. Moi H. Incidence and prevalence of dermatitis herpetiformis in a county in central Sweden with comments on the course of the disease and IgA deposits as a diagnostic criterion. Acta Derm Venereol 1984; 64: 144-50
3. Gawkrodger DJG, Blackwell JN, Gilmour HK, et al. Dermatitis herpetiformis, diagnosis, diet and demography. Gut 1984; 25: 151-7
4. Egan CA, O'Loughlin S, Gormally P, et al. Dermatitis herpetiformis: a review of fifty-four patients. Ir J Med Sci 1997; 166: 241-4
5. Sigurgeirsson B, Agnarsson BA, Lindelöf B. Risk of lymphoma in patients with dermatitis herpetiformis. BMJ 1994; 308: 13-5
6. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol 1997; 32: 1129-33
7. Hall RP, Clark RE, Ward FE. Dermatitis herpetiformis in two American blacks: HLA type and clinical characteristics. J Am Acad Dermatol 1990; 22: 436-9
8. Shibahara M, Nanko H, Shimizu M, et al. Dermatis herpetiformis in Japan: an update. Dermatology 2002; 204: 37-42
9. Karpati S, Kosnai I, Verkasalo M, et al. HLA antigens, jejunal morphology and associated diseases in children with dermatitis herpetiformis. Acta Paediatr Scand 1986; 75: 297-301
10. Ermacora E, Prampolini L, Tribbia G, et al. Long-term follow-up of dermatitis herpetiformis children. J Am Acad Dermatol 1986; 15: 24-30
11. Mäki M, Collin P. Coeliac disease. Lancet 1997; 349: 1755-9
12. Hervonen K, Hakanen M, Kaukinen K, et al. First-degree relatives are frequently affected in coeliac disease and dermatitis herpetiformis. Scand J Gastroenterol 2002; 37: 51-5
13. Meyer LJ, Zone JJ. Familial incidence of dermatitis herpetiformis. J Am Acad Dermatol 1987; 17: 643-7
14. Lähteenoja H, Irjala K, Viander M. et al. Oral mucosa is frequently affected in patients with dermatitis herpetiformis. Arch Dermatol 1998; 134: 756-8
15. Patinen P, Hietanen J, Malmström M, et al. Iodine and gliadin challenge on oral mucosa in dermatitis herpetiformis. Acta Derm Venereol 2002; 82: 86-9
16. van der Meer R. Granular deposits of immunoglobulins in the skin of the patients with dermatitis herpetiformis. Br J Dermatol 1969; 81: 493-503
17. Zone JJ, Meyer LJ, Petersen MJ. Deposition of granular IgA relative to clinical lesions in dermatitis herpetiformis. Arch Dermatol 1996; 132: 912-8
18. Beumer EH, Chorzelski TB, Reunala TL, et al. Immunopathology of dermatitis herpetiformis. Clin Dermatol 1992; 9: 295-311
19. Guide SV, Marinkovich MP. Linear IgA bullous dermatosis. Clin Dermatol 2001; 19: 719-27
20. Alexander JO, Dermatitis herpetiformis: major problems in dermatology. Vol. 4. London: WB Saunders, 1975
21. Chorzelski TP, Jablonska S, Maciejowska E. Linear IgA bullous dermatosis of adults. Clin Dermatol 1992; 9: 383-92
22. Logan RFA, Tucker G, Rifkind EA, et al. Changes in clinical features of coeliac disease in adults in Edinburgh and the Lothians 1960-79. BMJ 1983; 286: 95-7
23. Reunala T, Kosnai I, Karpati S, et al. Dermatitis herpetiformis: jejunal findings and skin response to gluten-free diet. Arch Dis Child 1984; 59: 517-22
24. Dieterich W, Ehnis T, Bauer M, et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med 1997; 3: 797-801
25. Lundin KEA, Scott H, Hansen T, et al. Gliadin-specific, HLA-DQ(α1*0501, β*0201) restricted T cells isolated from the small intestinal mucosa of celiac disease patients. J Exp Med 1993; 178: 87-96
26. Molberg O, McAdam SN, Korner R, et al. Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nat Med 1998; 4: 713-7
27. Schuppan D. Current concepts of celiac disease pathogenesis. Gastroenterology 2000; 119: 234-42
28. Aeschlimann D, Koeller MK, Allen-Hoffmann BL, et al. Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes. J Biol Chem 1998; 273: 3452-60
29. Raghunath M, Höpfner B, Aeschlimann D, et al. Cross-linking of the dermo-epidermal junction of skin regenerating from keratinocyte aurografts. J Clin Invest 1996; 98: 1174-84
30. Sárdy M, Kárpáti S, Merkl B, et al. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med 2002; 195: 747-57
31. Vogelsang H, Genser D, Wyatt J, et al. Screening for celiac disease: a prospective study on the value of noninvasive tests. Am J Gastroenterol 1995; 90: 394-8
32. Sulkanen S, Collin P, Laurila K, et al. IgA- and IgG-class antihuman umbilical cord antibody tests in adult coeliac disease. Scand J Gastroenterol 1998; 33: 251-4
33. Ladinser B, Rossipal E, Pittschieler K. Endomysium antibodies in coeliac disease: an improved method. Gut 1994; 35: 776-8
34. Dieterich W, Laag E, Schopper H, et al. Autoantibodies to tissue transglutaminase as predictors of celiac disease. Gastroenterology 1998; 115: 1317-21
35. Sulkanen S, Halttunen T, Laurila K, et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 1998; 115: 1322-8
36. Collin P, Mäki M, Keyriläinen O, et al. Selective IgA deficiency and coeliac disease. Scand J Gastroenterol 1992; 27: 367-71
37. Dieterich W, Laag E, Bruckner-Tuderman L, et al. Antibodies to tissue transglutaminase as serologic markers in patients with dermatitis herpetiformis. J Invest Dermatol 1999; 113: 133-6
38. Koop I, Ilchmann R, Izzi L, et al. Detection of autoantibodies against tissue transglutaminase in patients with celiac disease and dermatitis herpetiformis. Am J Gastroenterol 2000; 95: 2009-14
39. Aine L. Permanent tooth dental enamel defects leading to the diagnosis of coeliac disease. Br Dent J 1994; 177: 253-4
40. Ballinger A, Hughes C, Kumar P, et al. Dental enamel defects in coeliac disease. Lancet 1994; 343: 230-1
41. Aine L. Coeliac-type permanent tooth enamel defects. Ann Med 1996; 28: 9-12
42. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neuropscyhological, and neuropathological characteristics of gluten ataxia. Lancet 1998; 352: 1582-5
43. Valdimarsson T, Toss G, Ross I, et al. Bone mineral density in coeliac disease. Scand J Gastroenterol 1994; 29: 457-61
44. Mora S, Barera G, Beccio S, et al. Bone density and bone metabolism are normal after long-term gluten-free diet in young celiac patients. Am J Gastroenterol 1999; 94: 398-403
45. Marsh MN. Bone disease and gluten sensitivity: time to act, to treat, and to prevent. Am J Gastroenterol 1994; 89: 2105-7
46. Reunala T, Collin P. Diseases associated with dermatitis herpetiformis. Br J Dermatol 1997; 136: 315-8
47. Zettinig G, Weissel M, Flores J, et al. Dermatitis herpetiformis is associated with atrophic but not with goitrous variant of Hashimoto's thyroiditis. Eur J Clin Invest 2000; 30: 53-7
48. Cunningham MJ, Zone JJ. Thyroid abnormalities in dermatitis herpetiformis. Ann Intern Med 1985; 102: 194-6
49. Weetman AP, Burrin JM, Mackay D, et al. The prevalence of thyroid autoanti-bodies in dermatitis herpetiformis. Br J Dermatol 1988; 118: 377-83
50. Gaspari AA, Huang C-M, Davey RJ, et al. Prevalence of thyroid abnormalities in patients with dermatitis herpetiformis and in control subjects with HLA-B8/-DR3. Am J Med 1990; 88: 145-50
51. Collin P, Kaukinen K, Välimäki M, et al. Endocrinological disorders and celiac disease. Endocr Rev 2002; 23: 464-83
52. Fry L, Seah PP, Riches DJ, et al. Clearance of skin lesions in dermatitis herpetiformis after gluten withdrawal. Lancet 1973; 1: 288-91
53. Reunala T, Blomqvist K, Tarpila S, et al. Gluten-free diet in dermatitis herpetiformis: I. clinical response of skin lesions in 81 patients. Br J Dermatol 1977; 97: 473-80
54. Garioch JJ, Lewis HM, Sargent SA, et al. 25 years experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol 1994; 131: 541-5
55. Janatuinen EK, Pikkarainen PH, Kemppainen TA, et al. A comparison of diets with and without oats in adults with celiac disease. N Engl J Med 1995; 333: 1033-7
56. Hardman CM, Garioch JJ, Leonard JN, et al. Absence of toxicity of oats in patients with dermatitis herpetiformis. N Engl J Med 1997; 337: 1884-7
57. Reunala T, Collin P, Holm K, et al. Tolerance to oats in dermatitis herpetiformis. Gut 1998; 43: 490-3
58. Leonard JN, Fry L. Treatment and management of dermatitis herpetiformis. Clin Dermatol 1992; 9: 403-8
59. Collin P, Pukkala E, Reunala T. Malignancy and survival in dermatitis herpetiformis: a comparison with coeliac disease. Gut 1996; 38: 528-30
60. Leonard JN, Tucker WF, Fry JS. et al. Increased incidence of malignancy in dermatitis herpetiformis. BMJ 1983; 286: 16-8
61. Lewis HM, Reunala TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol 1996; 135: 363-7
62. Marsden RA. The treatment of benign bullous dermatosis of childhood, and dermatitis herpetiformis and bullous pemphigoid beginning in childhood. Clin Exp Dermatol 1982; 7 (6): 653-63
63. Prussick R, Ali MAM, Rosenthal D, et al. The protective effect of vitamin E on the hemolysis associated with dapsone treatment in patients with dermatitis herpetiformis. Arch Dermatot 1992; 128: 210-3
64. Hörnsten P, Keisu M, Wiholm B-E. The incidence of agranulosytosis during treatment of dermatitis herpetiformis with dapsone as reported in Sweden, 1972 through 1988. Arch Dermatol 1990; 126: 919-22
65. Coleman MD. Dapsone mediated agranulocytosis: risks, possible mechanism and prevention. Toxicology 2001; 162: 53-60
66. Kastrup W, Mobacken H, Stockbrugger R, et al. Malbabsorption of vitamin B12 in dermatitis herpetiformis and its association with pernicious anemia. Acta Med Scand 1986; 220: 261-8
67. Reunala T, Chorzelski TP, Viander M, et al. IgA anti-endomysial antibodies in dermatitis herpetiformis: correlation with jejunal morphology, gluten-free diet and antigliadin antibodies. Br J Dermatol 1987; 117: 185-91
68. Ventura A, Magazzu G, Greco L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. Gastroenterology 1999; 117: 297-303
69. Ferguson R, Basu MK, Asquith P, et al. Jejunal mucosal abnormalities in patients with recurrent aphthous ulceration. BMJ 1976; 1: 11-3
70. Ferguson MM, Wray D, Carmichael HA, et al. Coeliac disease associated with recurrent aphthae. Gut 1980; 21: 223-6
71. Wray D. Gluten-sensitive recurrent aphthous stomatitis. Dig Dis Sci 1981; 26: 737-40
72. Jokinen J, Peters U, Mäki M. et al. Celiac sprue in patients with chronic oral mucosal symptoms. J Clin Gastroenterol 1998; 26: 23-6
73. Corazza GR, Andreani ML, Venturo N, et al. Celiac disease and alopecia areata: report of a new association. Gastroenterology 1995; 109: 1333-7
74. Volta U, Bardazzi F, Zauli D, et al. Serological screening for coeliac disease in vitiligo and alopecia areata. Br J Dermatol 1997; 136: 801-2
75. Amato L, Gallerani I, Fuligini A, et al. Dermatitis herpetiformis and vitiligo: report a case and review of literature. J Dermatol 2002; 27: 462-6
76. de Vos RJ, de Boer WA. Haas FD. Is there a relationship between psoriasis and coeliac disease [letter]?. J Intern Med 1995; 237: 118
77. Lindqvist U, Rudsander Å, Bostrom Å, et al. IgA antibodies to gliadln and coeliac disease in psoriatic atrhritis. Rheumatology 2002; 41: 31-7